Cambridge UK antibody technology pioneer Kymab has won an important European patent battle against Regeneron.
Cambridge UK stem cell technology startup Axol Bioscience has secured £800,000 in new equity funding – bringing on board an elite team of heavy-hitters in the life-science investment world.
Intelligent Fingerprinting – the company behind a revolutionary non-invasive and real-time drug screening technique that analyses the sweat in a fingerprint – has been offered a substantial grant from the EUREKA Eurostars Programme that will allow its technology to be adapted and trialled in an Anglo-Finnish opioid drug rehabilitation study.
Neighbouring businesses Sphere Fluidics and Cambridge Consultants have joined forces to promote analysis technology that they believe will revolutionise biopharma.
Cambridge UK medical technology trailblazer Abcodia is working with OncoCyte Corporation in California to develop a new test for early detection of breast cancer.
Sphere Medical is set for commercial lift off with its new blood gas analyser, Proxima 3.
Cambridge UK medical technology company Consort Medical has completed production facilities to make a new nicotine inhaler for British American Tobacco.
Advanced technology based on neurostimulation devices such as chip implants will wire future patients for recovery against a range of conditions from migraine to Parkinson’s disease – even obesity – Cambridge UK MedTech experts are predicting.
Medical technology business Cambridge Cognition is cutting a swathe through legacy losses and charging towards profitability in 2015, CEO Nick Kerton has assured shareholders.
Jonathan Milner, who built Abcam from zero in 1998 to global life science hero in 2014, has stepped aside as CEO and handed the reins to chief marketing officer Alan Hirzel, who only joined the board in January.
Amgen and the University of Cambridge have joined forces to stage a venture designed to develop future life science leaders. The symposium is being held in Cambridge today and tomorrow.
Innova Biosciences, a specialist provider of bioconjugation products and services, has commercially launched InnovaGOLD – a new range of ultra-high quality gold nanoparticles.
International medical markets would appear to be beckoning for a fresh innovation from Cambridge-based hothouse Ranier Technology. The company has been granted a CE mark for its new fusion cage, Anatom-C, which is made from a unique polymeric material and provides critical support for people with spinal problems.
Isogenica has appointed Dr Chris Ullman as CEO with effect from September 29 following the decision by Dr Kevin Matthews to join a publicly listed polymer technology company.
Stem cell technology pioneer, DefiniGEN Ltd has joined the Pfizer-inspired European Bank for induced pluripotent stem cells (EBiSC) consortium.
Cambridge UK life science entrepreneur Dr Catherine Beech is spearheading a truly international startup initially targeting eye disease but with applications in cancer and other disease areas.
- Life science investor interest highest for 10 years
- Antitope and UCL collaborate on key antibody
- ARM takes SimPrints cash haul to half a million
- Vectura cashing in on transition success
- Cambridge-Canada assault on harmful drug side effects
- Cambridge Consultants tripling headcount at new US HQ
- Abcam on the up Down Under
- Optibrium launches drug discovery software
- Rapid Biosensor makes move to IPO
- Cannabis-based drug firm sees UK shares go to pot
- Fertility pioneer brings funding haul to $9m
- Machine learning advances help to tackle cancer
- GrowthAccelerator award for Lintbells
- Vernalis ready for US lift-off in 2015
- Gene editing world leaders boost Horizon SAB
- Vernalis cashes in on French connection
Page 1 of 63